This inventor holds 4 USPTO granted patents. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 1993-2001.
Company Filing History:
Years Active: 1993-2001
Title: Innovations of Johannes Pohlner
Introduction
Johannes Pohlner is a notable inventor based in Tubingen, Germany. He has made significant contributions to the field of genetic engineering, particularly in the development of hybrid live vaccines. With a total of 4 patents, his work has the potential to impact immunology and vaccine production.
Latest Patents
One of his latest patents is titled "Two-phase system for the production and presentation of foreign antigens in hybrid live vaccines." This invention relates to a genetic engineering process designed for the optimal production and exposure of additional antigens coded for by a live vaccine. The process utilizes spontaneous DNA reorganization in the recombinant live vaccine, resulting in the formation of two subpopulations. Subpopulation A is capable of infecting and acts immunogenically, while subpopulation B is regenerated by subpopulation A, producing additional antigens. This innovative approach ensures that the infection process necessary for inducing an immune response occurs without disturbing the formation of additional antigens, ultimately leading to an effective immune response.
Another patent involves "Bacteria for preparing stable fusion proteins and methods for detecting." This patent further showcases his expertise in the field and his commitment to advancing scientific knowledge.
Career Highlights
Johannes Pohlner is affiliated with the Max Planck Society for the Advancement of Science, a prestigious research institution known for its contributions to various scientific fields. His work at this institution has allowed him to collaborate with leading scientists and researchers.
Collaborations
Throughout his career, Pohlner has worked alongside notable colleagues such as Thomas F. Meyer and Gunter Schumacher. These collaborations have enriched his research and contributed to the success of his innovative projects.
Conclusion
Johannes Pohlner's contributions to genetic engineering and vaccine development are noteworthy. His innovative patents and collaborations with esteemed colleagues highlight his commitment to advancing science and improving public health.